Bionaut develops microscale robots to deliver biologics or small molecule therapies locally to targeted disease areas in the body, focusing on patients suffering from severe brain disorders.

Bionaut

Bionauts™ are remote-controlled micro-robots revolutionizing the treatment of central nervous system disorders, targeting deep brain structures safely and precisely

Revolution

Revolution’s Rise of the Rest Seed Fund

Khosla Ventures

Compound

Upfront Ventures

Bold Capital Partners

Public Safety Personnel Retirement System

Sixty Degree Capital

Deep Insight

Dolby Family Ventures

Gaingels

GISEV Family Office

Bionaut Labs

Thank you for including Bionaut Labs in the top 20 #Neurology companies advancing the field!

Thank you Healthcare Industry Future Growth for including Bionaut Labs in your latest report on AI solutions revolutionizing the pharma industry! Our AI pre-planning software automates the delivery of our micro-robots ensuring simple, consistent and repeatable drug delivery results.

Thank you Research Sphere Reports for including Bionaut Labs in your Nanorobots market research assessment. We're excited about being a leader in advancing the field of untethered micro-robotic healthcare technology! #nanorobots #drugdelivery #pharma #CNS

Thank you Dennis Slape, MBA at OSF Innovation for including Bionaut Labs in your list of companies advancing micro-robotics in healthcare!

"It is really customized for the pharma partner... and our business model is to partner with pharma to help get their (CNS) payloads to the target." 

Michael Shpigelmacher, CEO & Founder of Bionaut Labs, presented our cutting-edge micro-robotic CNS drug delivery platform at the BIO conference last week. We had many productive discussions with prospective pharma partners and are excited about the future collaborations to revolutionize targeted therapies and improve patient outcomes.

#BIO2024 #PharmaInnovation #Healthcare #Biotech #BigPharma #CNS #TargetedTherapies #Bionaut #DrugDelivery

The Bionaut Labs team will be at Biotechnology Innovation Organization's BIO International Convention next week! Reach out to Paul Schultz if you want to connect, and make sure to catch our CEO Michael Shpigelmacher's talk at 4:30 on Tuesday, June 4 in Room 4. #BIO2024

https://lnkd.in/gzP-mAub

Our CEO & Founder Michael Shpigelmacher will be presenting Bionaut Labs at the BIO International Convention in San Diego next Tue June 4th at 4:30 PM. Please stop by if you are attending to learn more!
#BIO2024

🎥 New Bionaut Video 

Take a glimpse into the groundbreaking work we're doing at Bionaut Labs! 

Our latest video showcases the intricate procedure of our first clinical program targeting Dandy Walker Malformation (DWM) using our innovative micro-robotic platform. We aim to get FDA clearance soon and look forward to bringing it to patients with the help of leading Neuro centers in the country including Mayo Clinic, Boston Children's Hospital and others.

Witness how Bionaut's technology navigates through the complexities of the human body with precision and efficiency, navigating directly to affected areas. This advancement holds immense promise for patients with DWM and marks a significant milestone in the field of medical robotics and neurosurgery.

As we continue to push the boundaries of what's possible in healthcare, we're proud to be at the forefront of innovation, driving meaningful change for patients and clinicians alike.

Watch the full video here [https://lnkd.in/gMQUMF4f] and join us in celebrating this remarkable achievement!

#Bionaut #MedicalRobotics #Innovation #Healthcare #DandyWalkerMalformation #Neurosurgery #MicroRobotics #DrugDelivery #ClinicalProgram #MedicalTechnology

Thank you Research Sphere Reports for highlighting Bionaut Labs micro-robotic drug delivery platform. Great to see the growth in this market!

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

logo

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	Sep 3, 2024 11:52 PM	6f110293
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Sep 3, 2024 11:56 PM	0d243c7e
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
peers	general	Sep 3, 2024 11:52 PM	4a4ccb9a
news basic	general	Sep 3, 2024 11:52 PM	2d10d1a4
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
logo	meta
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:BIONAUTLABS

Bionaut